Cognitive impairment in Parkinson's disease without dementia: Subtypes and influences of age

Journal of Clinical Neurology (Korea)

Volumn 5, Issue 3, 2009, Pages 133-138

  Kim, Jae Woo ^a   Cheon, Sang Myung ^a   Park, Min Jeong ^a   Kim, Seong Yeon ^a   Jo, Hee Young ^a  

^a Dong A University   (South Korea)

Author keywords

Mild cognitive impairment; Parkinson's disease; Parkinson's disease dementia

Indexed keywords

EID: 77955473850     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2009.5.3.133     Document Type: Article

References (22)

1. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia Mov Disord 2006;21:1343-1349.
2. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1272-1277.
3. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58:1985-1992.
4. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127(Pt 3):550-560.
5. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148.
6. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
7. Fahn S, Elton RI, Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Golstein M. Recent development in Parkinson's disease vol. 2. New York: Macmillan Health Care Information, 1987:153-164.
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
9. Kang Y, Na DL. Seoul Neuropsychological Screening Battery, Incheon: Human Brain Research & Consulting Co.,2003.
10. Lattin J, Carroll JD, Green P. Analyzing Multivariate Data. London: Duxbury,2003.
11. Kim H, Na DL. Normative data on the Korean version of the Boston Naming Test. J Clin Exp Neuropsychol 1999;21:127-133.
12. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson's disease. Neurology 2005;65:1239-1245.
13. Green J, McDonald WM, Vitek JL, Evatt M, Freeman A, Haber M, et al. Cognitive impairments in advanced PD without dementia. Neu-rology 2002;59:1320-1324.
14. Dubois B, Pillon B, Sternic N, Lhermitte F, Agid Y. Age-induced cognitive disturbances in Parkinson's disease. Neurology 1990;40:38-41.
15. Katzen H, Levin B, Llabre ML. Age of disease onset influences cognition in Parkinson's disease. J Int Neuropsychol Soc 1998;4:285-290.
16. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sør-ensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 2001;56:730-736.
17. Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000;54:1596-1602.
18. Uekermann J, Daum I, Peters S, Wiebel B, Przuntek H, Müller T. Depressed mood and executive dysfunction in early Parkinson's disease. Acta Neurol Scand 2003;107:341-348.
19. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
20. Boeve BF, Ferman TJ, Smith GE, Knopman DS, Jicha GA, Geda YE, et al. Mild cognitive impairment preceding dementia with Lewy bodies. Neurology 2004;62(suppl 5):A86-A87.
21. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
22. Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004;351:2509-2518.